BIAFW

USD

bioAffinity Technologies Inc. Warrant

$0.350-0.120 (-25.532%)

السعر في الوقت الحقيقي

Healthcare

Diagnostics & Research

الولايات المتحدة

مخطط الأسعار

Loading Chart...

المقاييس الرئيسية

مقاييس السوق

أساسيات الشركة

إحصاءات التداول

مقاييس السوق

الافتتاح

$0.470

الأعلى

$0.350

الأدنى

$0.350

الحجم

0.00M

أساسيات الشركة

الصناعة

Diagnostics & Research

البلد

United States

إحصاءات التداول

البورصة

NCM

العملة

USD

نطاق 52 أسبوعاً

الأدنى $0.35الحالي $0.350الأعلى $0.35

أخبار ذات صلة

٢٨ أكتوبر ٢٠٢٥ · ١٢:٠٠ م

BusinessWire

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Australian patent strengthens global patent portfolio bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company advancing early-stage diagnostics including CyPath® Lung, the Company's

عرض المزيد

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

٩ أكتوبر ٢٠٢٥ · ٠٥:٠٠ م

BusinessWire

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced it has closed the previously announced

عرض المزيد

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

٨ أكتوبر ٢٠٢٥ · ٠٧:٤٥ م

BusinessWire

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. (NASDAQ:BIAF, BIAFW)), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced that it has entered into definitive

عرض المزيد